64 related articles for article (PubMed ID: 17145918)
1. Surface-modified LPD nanoparticles for tumor targeting.
Li SD; Huang L
Ann N Y Acad Sci; 2006 Oct; 1082():1-8. PubMed ID: 17145918
[TBL] [Abstract][Full Text] [Related]
2. Tumor-targeted delivery of siRNA by self-assembled nanoparticles.
Li SD; Chen YC; Hackett MJ; Huang L
Mol Ther; 2008 Jan; 16(1):163-9. PubMed ID: 17923843
[TBL] [Abstract][Full Text] [Related]
3. Non-Viral Carriers for Nucleic Acids Delivery: Fundamentals and Current Applications.
Shtykalova S; Deviatkin D; Freund S; Egorova A; Kiselev A
Life (Basel); 2023 Mar; 13(4):. PubMed ID: 37109432
[TBL] [Abstract][Full Text] [Related]
4. Survivin Small Molecules Inhibitors: Recent Advances and Challenges.
Albadari N; Li W
Molecules; 2023 Feb; 28(3):. PubMed ID: 36771042
[TBL] [Abstract][Full Text] [Related]
5. Bio-Nanocarriers for Lung Cancer Management: Befriending the Barriers.
Rawal S; Patel M
Nanomicro Lett; 2021 Jun; 13(1):142. PubMed ID: 34138386
[TBL] [Abstract][Full Text] [Related]
6. Conventional Nanosized Drug Delivery Systems for Cancer Applications.
Vergallo C; Hafeez MN; Iannotta D; Santos HA; D'Avanzo N; Dini L; Cilurzo F; Fresta M; Di Marzio L; Christian C
Adv Exp Med Biol; 2021; 1295():3-27. PubMed ID: 33543453
[TBL] [Abstract][Full Text] [Related]
7. Small interfering RNA for cancer treatment: overcoming hurdles in delivery.
Charbe NB; Amnerkar ND; Ramesh B; Tambuwala MM; Bakshi HA; Aljabali AAA; Khadse SC; Satheeshkumar R; Satija S; Metha M; Chellappan DK; Shrivastava G; Gupta G; Negi P; Dua K; Zacconi FC
Acta Pharm Sin B; 2020 Nov; 10(11):2075-2109. PubMed ID: 33304780
[TBL] [Abstract][Full Text] [Related]
8. Development of a carrier system containing hyaluronic acid and protamine for siRNA delivery in the treatment of melanoma.
Yang J; Zhao R; Feng Q; Zhuo X; Wang R
Invest New Drugs; 2021 Feb; 39(1):66-76. PubMed ID: 32794135
[TBL] [Abstract][Full Text] [Related]
9. Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap.
Song W; Shen L; Wang Y; Liu Q; Goodwin TJ; Li J; Dorosheva O; Liu T; Liu R; Huang L
Nat Commun; 2018 Jun; 9(1):2237. PubMed ID: 29884866
[TBL] [Abstract][Full Text] [Related]
10. Delivery Pathway Regulation of 3',3″-Bis-Peptide-siRNA Conjugate via Nanocarrier Architecture Engineering.
Sun J; Qiu C; Diao Y; Wei W; Jin H; Zheng Y; Wang J; Zhang L; Yang Z
Mol Ther Nucleic Acids; 2018 Mar; 10():75-90. PubMed ID: 29499958
[TBL] [Abstract][Full Text] [Related]
11. Liposome-Protamine-DNA Nanoparticle-Mediated Delivery of Short Hairpin RNA Targeting Brachyury Inhibits Chordoma Cell Growth.
Hu Y; Singh R; Deng Z; Mintz A; Hsu W
J Biomed Nanotechnol; 2016 Oct; 12(10):1952-61. PubMed ID: 29360338
[TBL] [Abstract][Full Text] [Related]
12. Targeting HPV-infected cervical cancer cells with PEGylated liposomes encapsulating siRNA and the role of siRNA complexation with polyethylenimine.
Levine RM; Dinh CV; Harris MA; Kokkoli E
Bioeng Transl Med; 2016 Jun; 1(2):168-180. PubMed ID: 29313012
[TBL] [Abstract][Full Text] [Related]
13. Dual Functional LipoMET Mediates Envelope-type Nanoparticles to Combinational Oncogene Silencing and Tumor Growth Inhibition.
Shi K; Zhao Y; Miao L; Satterlee A; Haynes M; Luo C; Musetti S; Huang L
Mol Ther; 2017 Jul; 25(7):1567-1579. PubMed ID: 28274796
[TBL] [Abstract][Full Text] [Related]
14. Towards Targeted Delivery Systems: Ligand Conjugation Strategies for mRNA Nanoparticle Tumor Vaccines.
Phua KK
J Immunol Res; 2015; 2015():680620. PubMed ID: 26819957
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of drug loading, pharmacokinetic behavior, and toxicity of a cisplatin-containing hydrogel nanoparticle.
Kai MP; Keeler AW; Perry JL; Reuter KG; Luft JC; O'Neal SK; Zamboni WC; DeSimone JM
J Control Release; 2015 Apr; 204():70-7. PubMed ID: 25744827
[TBL] [Abstract][Full Text] [Related]
16. Composite nanoparticles for gene delivery.
Wang Y; Huang L
Adv Genet; 2014; 88():111-37. PubMed ID: 25409605
[TBL] [Abstract][Full Text] [Related]
17. Nanopreparations to overcome multidrug resistance in cancer.
Patel NR; Pattni BS; Abouzeid AH; Torchilin VP
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1748-62. PubMed ID: 23973912
[TBL] [Abstract][Full Text] [Related]
18. Synergetic Targeted Delivery of Sleeping-Beauty Transposon System to Mesenchymal Stem Cells Using LPD Nanoparticles Modified with a Phage-Displayed Targeting Peptide.
Ma K; Wang DD; Lin Y; Wang J; Petrenko V; Mao C
Adv Funct Mater; 2013 Mar; 23(9):1172-1181. PubMed ID: 23885226
[TBL] [Abstract][Full Text] [Related]
19. Biodegradable polysilsesquioxane nanoparticles as efficient contrast agents for magnetic resonance imaging.
Vivero-Escoto JL; Rieter WJ; Lau H; Huxford-Phillips RC; Lin W
Small; 2013 Oct; 9(20):3523-31. PubMed ID: 23613450
[TBL] [Abstract][Full Text] [Related]
20. Intelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapy.
Ramishetti S; Huang L
Ther Deliv; 2012 Dec; 3(12):1429-45. PubMed ID: 23323560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
